PT1706094T - Treatment of ophthalmic conditions - Google Patents
Treatment of ophthalmic conditionsInfo
- Publication number
- PT1706094T PT1706094T PT04814801T PT04814801T PT1706094T PT 1706094 T PT1706094 T PT 1706094T PT 04814801 T PT04814801 T PT 04814801T PT 04814801 T PT04814801 T PT 04814801T PT 1706094 T PT1706094 T PT 1706094T
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- ophthalmic conditions
- ophthalmic
- conditions
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA2003011987 | 2003-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1706094T true PT1706094T (en) | 2018-10-29 |
Family
ID=61074632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT04814801T PT1706094T (en) | 2003-12-19 | 2004-12-17 | Treatment of ophthalmic conditions |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6696952B2 (en) |
DK (1) | DK1706094T3 (en) |
ES (1) | ES2688599T3 (en) |
PT (1) | PT1706094T (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5270051A (en) * | 1991-10-15 | 1993-12-14 | Harris Donald H | Enzyme-orthokeratology |
-
2004
- 2004-12-17 PT PT04814801T patent/PT1706094T/en unknown
- 2004-12-17 DK DK04814801.9T patent/DK1706094T3/en active
- 2004-12-17 ES ES04814801.9T patent/ES2688599T3/en active Active
-
2017
- 2017-10-31 JP JP2017210444A patent/JP6696952B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ES2688599T3 (en) | 2018-11-05 |
JP2018016646A (en) | 2018-02-01 |
JP6696952B2 (en) | 2020-05-20 |
DK1706094T3 (en) | 2018-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24420A (en) | Treatment of ophthalmic conditions | |
EP1755584A4 (en) | Treatment of myopia | |
IL173351A0 (en) | Therapy of ocular disorders | |
GB2415378B (en) | Treatment of neurodegenerative conditions | |
GB2422373B (en) | Treatment of neurodegenerative conditions | |
EP1617844A4 (en) | Treatment of neurological conditions | |
GB0404656D0 (en) | Treatment of spinal conditions | |
GB0320238D0 (en) | Treatment of disease | |
PL371281A1 (en) | Methods and compositions for the treatment of eye diseases | |
EP1651237A4 (en) | Methods for treatment of dermatological conditions | |
EP1675547A4 (en) | Glucocerebroside treatment of disease | |
GB0306309D0 (en) | Method of treatment | |
IL174595A0 (en) | Glucocerebroside treatment of disease | |
GB0302572D0 (en) | Method of treatment | |
GB0300783D0 (en) | Treatment of neurodegenerative conditions | |
EP1691776A4 (en) | Treatment of aids | |
GB0217493D0 (en) | Novel methods of treatment | |
GB0221712D0 (en) | Methods of treatment | |
GB0327975D0 (en) | Methods of treatment | |
PT1706094T (en) | Treatment of ophthalmic conditions | |
HU0302933D0 (en) | Treatment of diseases | |
GB0312289D0 (en) | Treatment of the eye | |
GB0322921D0 (en) | Methods of treatment | |
AU2004905035A0 (en) | Treatment of Ophthalmic Conditions | |
GB0313801D0 (en) | Novel methods of treatment |